| __timestamp | Bausch Health Companies Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 12122000 |
| Thursday, January 1, 2015 | 582800000 | 13380000 |
| Friday, January 1, 2016 | 455000000 | 21221000 |
| Sunday, January 1, 2017 | 366000000 | 26887000 |
| Monday, January 1, 2018 | 414000000 | 27863000 |
| Tuesday, January 1, 2019 | 471000000 | 55908000 |
| Wednesday, January 1, 2020 | 452000000 | 59392000 |
| Friday, January 1, 2021 | 465000000 | 69012000 |
| Saturday, January 1, 2022 | 529000000 | 36082000 |
| Sunday, January 1, 2023 | 604000000 | 24537000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bausch Health Companies Inc. and Ligand Pharmaceuticals Incorporated have demonstrated contrasting strategies in their R&D investments. Bausch Health has consistently outpaced Ligand, with its R&D expenses peaking at approximately 604 million USD in 2023, marking a 145% increase from 2014. In contrast, Ligand's R&D spending reached its zenith in 2021, with a modest 69 million USD, reflecting a more conservative approach.
This disparity highlights the differing scales and strategies of these companies. While Bausch Health's robust investment underscores its commitment to innovation, Ligand's more measured spending suggests a focus on strategic partnerships and licensing. As the pharmaceutical landscape continues to shift, these R&D trends offer a glimpse into the future trajectories of these industry players.
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
R&D Spending Showdown: Zoetis Inc. vs Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited